You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mineralocorticoid receptor antagonist (MRA)

Showing 1 - 25 of 8,252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Failure With Reduced Ejection Fraction Trial in Los Angeles (Email Nudge)

Not yet recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Email Nudge
  • Los Angeles, California
    University of California, Los Angeles
Apr 7, 2023

s to Learn More About Treatment With Steroidal Mineralocorticoid

Active, not recruiting
  • Chronic Kidney Disease
  • +2 more
  • sMRA therapies
  • Whippany, New Jersey
    Many Locations
Jan 30, 2023

Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)

Not yet recruiting
  • Primary Aldosteronism
  • Hypertension
  • (no location specified)
Apr 3, 2023

Heart Failure, Hyperkalemia Trial in Gothenburg (Sodium zirconium cyclosilicate, Placebo)

Recruiting
  • Heart Failure
  • Hyperkalemia
  • Sodium zirconium cyclosilicate
  • Placebo
  • Gothenburg, Sweden
    Sahlgrenska University Hospital-Ostra Hospital
Sep 20, 2021

Chronic Kidney Diseases Trial (Mineralocorticoid receptor antagonist, Placebo)

Not yet recruiting
  • Chronic Kidney Diseases
  • Mineralocorticoid receptor antagonist
  • Placebo
  • (no location specified)
Sep 21, 2023

Primary Aldosteronism, Resistant Hypertension, Secondary Hypertension Trial in Boston (Best Practice Advisory Computerized

Not yet recruiting
  • Primary Aldosteronism
  • +5 more
  • Best Practice Advisory Computerized Alert
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 22, 2023

COVID-19 Pneumonia Trial in Szczecin (Canrenoate Potassium, Normal Saline)

Recruiting
  • COVID-19 Pneumonia
  • Canrenoate Potassium
  • Normal Saline
  • Szczecin, Poland
    Pomeranian Medical University
Jun 3, 2021

Hypotension, Heart Failure Trial in Taipei (Dapagliflozin, Sacubitril-Valsartan, Beta blocker)

Completed
  • Hypotension
  • Heart Failure
  • Taipei, Taiwan
    Cheng Hsin General Hospital
Jul 27, 2021

Heart Failure Trial in Worldwide (Spironolacton)

Completed
  • Heart Failure
  • Corbeil-Essonnes, France
  • +8 more
Mar 7, 2022

Heart Failure, Cardiomyopathy, Dilated, Cardiomyopathies Trial (Other)

Not yet recruiting
  • Heart Failure
  • +3 more
  • (no location specified)
Oct 17, 2023

Primary Aldosteronism, Hypertension Trial (Eplerenone)

Not yet recruiting
  • Primary Aldosteronism
  • Hypertension
  • (no location specified)
Aug 26, 2021

Primary Aldosteronism Trial in Montréal (Renin measurements)

Not yet recruiting
  • Primary Aldosteronism
  • Renin measurements
  • Montréal, Quebec, Canada
    Hôpital du Sacré-Coeur de Montréal
Oct 30, 2023

Acute Heart Failure Trial

Not yet recruiting
  • Acute Heart Failure
    • (no location specified)
    May 9, 2023

    Renin Angiotensin Aldosterone System Genetic Polymorphism on

    Recruiting
    • Myocardial Infarction
      • Cairo, Egypt
        Ain Shams University
      May 16, 2023

      Heart Failure Trial in Palo Alto (Audit and Feedback Emails, Patient Specific Targets, Educational Resources)

      Not yet recruiting
      • Heart Failure
      • Audit and Feedback Emails
      • +2 more
      • Palo Alto, California
        Palo Alto Veteran's Affairs Hospital
      Oct 24, 2023

      Type 2 Diabetes, Chronic Kidney Diseases Trial in Saga (Finerenone, Placebo)

      Not yet recruiting
      • Type 2 Diabetes
      • Chronic Kidney Diseases
      • Saga, Japan
        Saga University Hospital
      Jun 5, 2023

      Optimized Peak VO2 in Predicting Advanced HF

      Completed
      • Heart Failure
      • +2 more
      • cardiopulmonary exercise test
      • (no location specified)
      Jan 16, 2022

      Water and Electrolytes Content in HYpertension (WHYSKI) in SKIn

      Recruiting
      • Hyperaldosteronism
      • +7 more
      • Skin Biopsy
      • Video-laparoscopic adrenalectomy
      • Padova, Italy
        Azienda Ospedale Università di Padova
      Oct 23, 2023

      Heart Failure With Reduced Ejection Fraction Trial (Pharmacist-led HFrEF medication optimization, Usual care)

      Not yet recruiting
      • Heart Failure With Reduced Ejection Fraction
      • Pharmacist-led HFrEF medication optimization
      • Usual care
      • (no location specified)
      Nov 14, 2022

      Primary Hyperaldosteronism Due to Adrenal Adenoma Trial in Gothenburg, Stockholm, Umeå (Unilateral adrenalectomy, Medical

      Not yet recruiting
      • Primary Hyperaldosteronism Due to Adrenal Adenoma
      • Unilateral adrenalectomy
      • Medical treatment (eplerenone)
      • Gothenburg, Sweden
      • +2 more
      Mar 30, 2023

      Heart Failure, Systolic Trial (Biofourmis Digital Platform)

      Not yet recruiting
      • Heart Failure, Systolic
      • Biofourmis Digital Platform
      • (no location specified)
      Aug 4, 2023

      Heart Failure With Mid-range Ejection Fraction, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (Experimental:

      Recruiting
      • Heart Failure With Mid-range Ejection Fraction
      • Heart Failure With Preserved Ejection Fraction
      • Experimental: Spironolactone
      • Placebo Comparator
      • Graz, Austria
      • +68 more
      Jan 28, 2021

      Glucose Metabolism in Aldosterone-Producing Adenomas

      Completed
      • Primary Aldosteronism
      • Adrenalectomy
      • mineralocorticoid receptor antagonist
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Apr 28, 2021

      Heart Failure With Reduced Ejection Fraction Trial in New Haven (Best Practice Alert)

      Recruiting
      • Heart Failure With Reduced Ejection Fraction
      • Best Practice Alert
      • New Haven, Connecticut
        Cardiology/Internal Medicine Outpatient Clinics of Yale New Heal
      Jan 17, 2022

      Patterns in Patients in Colombia Who Have Heart Failure

      Active, not recruiting
      • Heart Failure
      • HF medication
      • Multiple Locations, Colombia
        Many Locations
      Jul 26, 2022